Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs.
Biomark Res
; 3: 9, 2015.
Article
in En
| MEDLINE
| ID: mdl-26015868
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Biomark Res
Year:
2015
Document type:
Article